Picture of Cullinan Therapeutics logo

CGEM — Cullinan Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Cullinan Oncology Q2 Adjusted Net Income USD -32.2 Million

Aug 10 (Reuters) - Cullinan Oncology Q2 cash & investments USD 512.1 million

Recent news on Cullinan Therapeutics

See all news